NFKB1 and pulmonary emphysema: miR-195-5p suppresses COPD development by targeting siglec1 and inactivating NF-κB signaling (53), while miR-146a deficiency results in increased emphysema severity and enhanced pro-inflammatory mediator production in murine models (55).